| Ytd | -31.19% | |
| 1y | -21.62% |
| Open | 1.82 | Prev Close | 1.82 | Low | 1.82 | High | 2.06 | Mkt Cap | 79.49M |
| Vol | 24.31K | Avg Vol | 50.66K | EPS | -0.64 | P/E | N/A | Forward P/E | -16.23 |
| Beta | 1.04 | Short Ratio | 11.21 | Inst. Own | 71.54% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 1.94 | 200-d Avg | 2.63 | 1yr Est | 2.75 |
SALT LAKE CITY, June 30, 2026 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq:
Sera Prognostics Inc., The Pregnancy Company® (NASDAQ:SERA), focused on improving maternal and neona
Craig-Hallum analyst Bill Bonello initiates coverage on Sera Prognostics (NASDAQ:SERA) with a Buy